Research And Foundation
A global consortium that is spearheading research.
The Head and Neck and Thyroid Cancer Institute of Mount Sinai Beth Israel in New York, New York, collaborates with The Institute for Reconstruction Sciences in Medicine in Edmonton, Alberta, Canada, the University of Turku and Turku University Hospital in Finland, and the University Medical Center Freiburg, Department of Maxillofacial Surgery, Freiburg, Germany, by gathering data to improve patient diagnosis, treatment and care.
Because fewer patients are affected by head and neck cancer and thyroid cancer than other cancers, effective research requires a pooling of patient data. Through collaboration, these institutions share outcomes information that is clinically significant — contributing to the improvement of patient treatment.
Research efforts are headquartered in the Institute of Head and Neck and Thyroid Cancer at Mount Sinai Beth Israel’s Phillips Ambulatory Care Center (PACC), 10 Union Square East. The space, contiguous to the Head and Neck and Thyroid Cancer Institute’s central offices, makes it convenient for patients to be followed and data to be collected. The dedicated research area includes two specially outfitted patient treatment rooms and areas for visiting scholars, fellows and observers.
THANC (Thyroid, Head and Neck Cancer Foundation) funding.
Incorporated in 2003, THANC is the first independent foundation dedicated specifically to head and neck cancer and thyroid cancer research, education and patient support. It is the largest private funder of research in the areas of head and neck cancer and thyroid cancer in the nation and is committed to advancing new therapeutic approaches and alleviating the suffering and functional impairment of patients with these diseases.